Gratiago was born from a simple conviction: a treatment only works if the patient truly follows it. Here is where we come from and where we are going.
At the origin of Gratiago lies a personal experience: that of a patient facing the reality of living with a chronic illness, the difficulty of maintaining a treatment day to day, the fear of side effects and the lack of support between consultations.
From this experience came the Gratiago Method®: a behavioural approach to reconcile the patient with their treatment, co-built with doctors, scientists and experts in health behaviour change.
Founded in 2022 in Brussels, Gratiago shaped this method into a digital platform, validated in real clinical conditions, and now deployed in partnership with pharmaceutical companies and committed clinicians.
The medicine of tomorrow will not only be more precise. It will be more mindful.
At Gratiago, we believe that technology should augment people, not replace them. That the patient is an active participant in their health, not merely the recipient of a treatment. And that behavioural data, used well, is a new form of clinical intelligence in the service of everyone.
Our ambition: to make every act of care an act of awareness. And to build, condition by condition, the infrastructure that lets this connection hold: between the consultation and the dose, between the doctor and the patient.
Four complementary profiles brought together around the same conviction: reconciling the patient with their treatment.






GRACE-001 study site
For any press enquiry, high-resolution photos or interview request, write to us. We reply within 48 working hours. Contact us
Discover what Gratiago can offer to patients and health partners alike.